Skip to content
Vision Brit Today

Patients Discontinuing Weight-Loss Medications Gain Back Weight Four Times Faster Than People Using Diet and Exercise

Image of pharmaceutical syringe and scale
Obesity treatment often requires long-term strategies.

Fresh analysis indicates that patients who discontinue popular weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who halt conventional diet and exercise regimens.

Published data in a leading medical journal shows that while obese individuals frequently drop about a fifth of their total mass while using the jabs, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying such drugs need to be cognizant of the risk of fast weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.

That rate of regain implies a reversion to pre-treatment weight within about one and a half years.

Comparing Treatments

The study, which looked at dozens of trials involving thousands of patients, compared the effects of the injectable medications with conventional dieting.

The team point out that individuals who shed pounds through diet and exercise typically see a slower creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Fast Regain

Nutrition scientists propose the way of the jabs explains the accelerated weight return.

These medications copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Long-term administration of GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication leads to appetite is no longer kept in check, making overeating a significant risk."

A Chronic Condition?

Health authorities recommend the jabs for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.

Many experts say that, considering the high risk of weight regain, the therapy should be considered life-long.

This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent character of obesity," similar to managing conditions like high blood pressure.

User Experiences

Individuals who have discontinued the jabs explain a powerful return of appetite.

"It felt as if a trigger that goes on and you're instantly ravenous," described an individual.

This challenge is exacerbated if individuals have not established lasting lifestyle or habit changes during treatment.

Widespread Interest

Figures suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.

  • Use is higher among women than men.
  • The 40s and 50s demographic shows the greatest level of interest.
  • A large proportion obtain the drugs through private healthcare rather than the NHS.

In conclusion, experts emphasize that while the jabs are potent tools for shedding pounds, they are not a permanent cure and long-term success relies on integrated lifestyle changes.

Written by

Christopher Baker

A seasoned journalist with over a decade of experience covering UK politics and social trends, known for her sharp analysis.

Vision Brit Today

Type to search articles.